Scientia Ventures
Venture capitalNew York · Series A–Series B · 13 people tracked
Also known as VANTAGE CONSULTING GROUP INC
Investment thesis
Scientia Ventures targets novel and unique innovations with breakthrough potential, concentrating on the science and technology advances required to achieve radical change. As a global firm, it aims to pair the expertise and network of its team with visionary entrepreneurs, using its experience, deep network, and flexible approach as a proprietary edge. The team works to identify optimal strategic approaches and solutions for its portfolio companies, and its investors and general partners take a long-term view of venture success.
Source: firm website, verified Aug 11, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 17 of 32 portfolio companiesBiotech ×10Healthtech ×10SaaS ×4AgTech ×3Fintech ×3Medical Devices ×3AI & Machine Learning ×2Digital Health ×2
HQs:United States×8
Investments · 32 tracked
founders shown can be your intro pathBy year:2016 · 12015 · 12014 · 24 dated
ADC Therapeutics is a biopharmaceutical company that develops antibody drug conjugates and other therapies focused on hematology and oncology.
BiotechHealthtechMedical Devices
Ameet Mallik(Chief Executive Officer)Jose Carmona(Chief Financial Officer)Mohamed Zaki(Chief Medical Officer)Kristen Harrington-Smith(Chief Commercial Officer)David Ege(Chief Technical Officer)Peter Graham(Chief Legal Officer)
Leader in post-GMO precision gene editing for agricultural traits.
Acquires royalty interests in marketed and late-stage biopharmaceutical products, with over $12 billion in total assets across more than 40 products.
AgTechSan Diego, US
Alain Pompidou(Director)Peter Beetham(Chief Executive Officer)Richard D. Spizzirri, Ph.D.(Director)Jean Pierre Lehmann(Director)Eugene Linden(Director)Rory Riggs(Chairman of the Board)
Board seatMark FinnRory Riggs· per SEC Form D · $80M raise · filed Jul 2018
Hollywood, US
Barbara Rohan(Director)William Whitaker(Chief Operating Officer)Gil Perry(Executive Officer)Steven Griffin(President)
Board seatRory RiggsJonathan Finn· per SEC Form D · filed Jan 2015
BiotechMarkham
Leslie Auld(Executive Officer, Director)James Howard-Tripp(Executive Officer, Director)Heiner Dreismann(Director)Garth MacRae(Director)
Board seatRory RiggsHarry Glorikian· per SEC Form D · $7.4M raise · filed Feb 2022
Develops proprietary Antibody Drug Conjugates for treating solid and hematological cancers.
Biotechnology company focused on fibrotic and cardiovascular disorders.
eReceivables provides healthcare claims recovery and underpayment forensics through its Claim Axis platform, which automates payer appeals, timed escalations, and resolution for denied, aged, and small-balance claims.
FintechHealthtechSaaS
Warm Health Technology builds mobile health (mHealth) platforms for people living with chronic conditions and their healthcare providers, supporting collaborative management of health and well-being.
Digital HealthHealthtech
PayEase operates a payment platform offering internet payments, mobile payments, cross-border payments, foreign card acquiring, and foreign-trade collections for businesses.
FintechSaaS
Royalty Pharma is a buyer of biopharmaceutical royalties and a funder of life sciences innovation, providing tailored funding solutions and partnerships to biopharma companies.
BiotechFintech
Sprout Pharmaceuticals is a pharmaceutical company focused on women's sexual health, known for developing Addyi (flibanserin), the first FDA-approved treatment for low libido in women.
BiotechFemTechHealthtech
Cindy Eckert(Founder)
Intelinair provides crop intelligence through its AGMRI platform, which uses aerial imagery, computer vision, and machine learning to detect issues such as nutrient deficiency, weeds, crop stress, and underperforming field areas across the growing season.
AgTechAI & Machine LearningSaaSSan Jose, US
Naira Hovakimyan(Chief Scientific Officer and Secretary)Alfred Eisaian(President and Chief Executive Officer)
Rose Pharma is a pharmaceutical company developing ROSE-010, an on-demand GLP-1 therapy aimed at treating acute pain from irritable bowel syndrome (IBS) as well as obesity and appetite control.
BiotechHealthtech
VERIGRAFT develops technology that modifies donated tissue so it resembles a patient's own tissue, aiming to eliminate immune rejection in transplantation and reduce the need for lifelong immunosuppressants.
BiotechHealthtechMedical Devices
Petter Björquist(PhD, Chief Executive Officer)
Biopharmaceutical company founded by Nobel laureate Paul Greengard.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 3
IPOs and acquisitions across the tracked portfolioADC Therapeutics SANYSE: ADCTCibusNASDAQ: CBUSRoyalty PharmaNASDAQ: RPRX
Portfolio news
latest coverage across their companies1910 · tobaccoreporter.com · Sep 10, 2025
Frequently asked questions
- What stage does Scientia Ventures invest at?
- Scientia Ventures invests at the Series A, Series B stages.
- What sectors does Scientia Ventures focus on?
- Scientia Ventures focuses on Biotech, Deep Tech, Healthtech, Medical Devices.
- Where is Scientia Ventures located?
- Scientia Ventures is headquartered in New York, US.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.